Quadrant Biosciences Inc. is pleased to announce Clarifi!
Quadrant Biosciences, Inc. develops clinical assessment and molecular diagnostic tools to aid physicians in assessing brain health and to support rapid and accurate diagnoses of brain-based disorders. The company’s tests are expected to improve the diagnosis, monitoring, and treatment for serious health conditions including autism spectrum disorder, concussion, and Parkinson's Disease. Quadrant collaborates with leading research institutions and hospitals to develop novel saliva-based tests that measure epigenetic biomarkers related to genetic and microbiome expression patterns underlying these disorders. Products include the FDA-compliant ClearEdge® Brain Health Toolkit for functional assessment of neurological disorders and the Clarifi® epigenetic biomarker panel to aid clinicians in the diagnosis of autism spectrum disorder. Quadrant Biosciences is a participant in START-UP NY, a New York State economic development program. For more information about the company, contact info@QuadrantBiosciences.com.
Brands: Clarifi autism saliva test is an easy to administer biomarker test to support the diagnosis of ASD in children as young as 18 months.